From Wuthering Heights to Mario Tennis Fever: your complete entertainment guide to the week ahead 14 February 2026 at 01:00

From Wuthering Heights to Mario Tennis Fever: your complete entertainment guide to the week ahead

14 February 2026 at 01:00

Emerald Fennell’s film brings the raunch to Brontë’s romance, while Nintendo’s beloved plumber stars in a colourful, family-friendly sports game

Wuthering Heights
Out now
Out on the wily, windy moors, writer-director Emerald Fennell has constructed a new interpretation of the Emily Brontë classic. Margot Robbie is Cathy while Jacob Elordi takes on Heathcliff, and as you might expect from the film-maker behind Saltburn, the passionate pair are set to leave no height unwuthered.

Tutu review – cheeky tribute to ballet has a disco Swan Lake and the Dirty Dancing lift 12 February 2026 at 15:00

Tutu review – cheeky tribute to ballet has a disco Swan Lake and the Dirty Dancing lift

The Guardian

By:Lyndsey Winship

12 February 2026 at 15:00

Sadler’s Wells East, London
The all-male French troupe Chicos Mambo mix parody and pointework in a fast-paced comic celebration of dance’s high art and sillier side

When the curtain goes up here in east London, just across town there’s another opening night: fans gathering to worship the late dance theatre icon Pina Bausch, whose Sweet Mambo is at Sadler’s Wells. Whereas on this stage, six men send up Bausch’s choreography and signature style, skewering its cliches. Not that everyone in the audience will know the reference. If you’re not a regular dance-goer, you may just see a bunch of men in long flowing gowns processing around the stage and flinging their long wigs about. But still entertaining.

A lot of Tutu, after all, is just about raising mirth through silly dancing and silly costumes. All-male comedy dance company Chicos Mambo, directed by French choreographer Philippe Lafeuille, have been performing this show for more than a decade, and it seems to be a camp crowd-pleaser. Certainly the costumes are fun: puffy, flamingo-coloured tutu trousers, like a cross between a powder puff and a frilly toilet roll cover; hats that look like vegetables (Why? Why not!).

At Sadler’s Wells East, London, until 15 February

US FDA Reissues Cybersecurity Guidance to Reflect QMSR Transition and ISO 13485 Alignment 5 February 2026 at 04:12

US FDA Reissues Cybersecurity Guidance to Reflect QMSR Transition and ISO 13485 Alignment

Cybersecurity News and Magazine

By:Ashish Khaitan

5 February 2026 at 04:12

FDA Cybersecurity Guidance

The US Food and Drug Administration (FDA) has reissued its final guidance on medical device cybersecurity to reflect the agency’s transition from the Quality System Regulation (QSR) to the Quality System Management Regulation (QMSR). The updated FDA cybersecurity guidance was published on 4 February, just two days after the QMSR officially took effect. The revision updates regulatory references throughout the document and aligns cybersecurity expectations with the new quality system framework under 21 CFR Part 820, which now incorporates ISO 13485 by reference. According to the agency, the FDA cybersecurity guidance revisions were made under Level 2 guidance procedures. “Revisions issued [were] under Level 2 guidance procedures (21 CFR 10.115(g)(4)), including revisions to align with the amendments to 21 CFR 820 (the Quality Management System Regulation (QMSR)),” the FDA stated. The agency added that the updated document supersedes the final guidance titled Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions, which was published in June last year. Throughout the revised FDA cybersecurity guidance, references to the former QSR have been replaced with references to the QMSR. The agency also updated the guidance to consistently reference ISO 13485, reflecting its central role in the new regulatory structure designed to harmonize US requirements with those of other global regulatory authorities.

QMSR Framework Reshapes FDA Cybersecurity Guidance and Quality System Expectations

The QMSR became effective on 2 February and amended the device's current good manufacturing practice (CGMP) requirements under 21 CFR Part 820. These CGMP requirements were first authorized under section 520(f) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and initially codified in 1978. Significant revisions followed in 1996, when the FDA added design controls and sought closer alignment with international standards, including ISO 9001 and the early versions of ISO 13485. With the QMSR, the FDA formally incorporated by reference ISO 13485:2016, Medical devices – Quality management systems – Requirements for regulatory purposes, as well as Clause 3 of ISO 9000:2015, which covers quality management system fundamentals and vocabulary. The agency stated that this approach promotes consistency in quality system requirements across global markets while reducing regulatory burden on manufacturers. The QMSR applies to finished device manufacturers intending to commercially distribute medical devices in the United States. A finished device, as defined in 21 CFR 820.3(a), includes any device or accessory suitable for use or capable of functioning, regardless of whether it is packaged, labeled, or sterilized. Certain components, such as blood tubing and diagnostic x-ray components, are considered finished devices when they function as accessories and are therefore subject to QMSR requirements. Although some devices are exempt from CGMP requirements under classification regulations in 21 CFR Parts 862 through 892, those exemptions do not eliminate obligations related to complaint handling or recordkeeping. In addition, devices manufactured under an investigational device exemption are not exempt from design and development requirements under 21 CFR 820.10(c) of the QMSR or the corresponding ISO 13485 provisions.

FDA Cybersecurity Guidance Emphasizes QMSR-Based Design, Risk, and Inspection Changes

The revised FDA cybersecurity guidance reiterates that documentation outputs demonstrating adherence to the QMSR can be used to address cybersecurity risks and provide reasonable assurance of safety and effectiveness. The agency directs sponsors to specific ISO 13485 clauses to support this approach. For example, the FDA noted that “21 CFR 820.10(c) requires that for all classes of devices automated with software, a manufacturer must comply with the requirements in Design and Development, Clause 7.3 and its subclauses of ISO 13485.” The guidance highlights ISO 13485 Subclause 7.3.7, which requires design and development validation to ensure that a product is capable of meeting requirements for its specified application or intended use. “Design and development validation includes validation of device software,” the agency stated. The FDA also pointed to Subclause 7.1 of ISO 13485, which specifies that organizations must document one or more processes for risk management in product realization, an expectation closely tied to cybersecurity risk controls. As part of the update, the FDA removed a substantial section from the prior guidance that referenced former QSR design control provisions, including requirements under 21 CFR 820.30(c) and (d) related to design inputs and design outputs. Those provisions are no longer cited in the updated FDA cybersecurity guidance. The transition to QMSR also introduced changes to FDA inspection practices. Beginning on 2 February, the agency stopped using the Quality System Inspection Technique (QSIT) and began conducting inspections under the updated Inspection of Medical Device Manufacturers Compliance Program: 7382.850. At the same time, the FDA discontinued use of Compliance Programs 7382.845 and 7383.001, which previously governed device manufacturer and PMA-related inspections.

Netflix says users can cancel service if HBO Max merger makes it too expensive 3 February 2026 at 18:41

Netflix says users can cancel service if HBO Max merger makes it too expensive

Ars Technica

By:Scharon Harding

3 February 2026 at 18:41

A potential deal between Netflix and Warner Bros. Discovery’s (WBD) streaming and movie studio businesses has raised fresh concerns about consolidation in the streaming industry. Attempting to quell fears that an acquisition of WBD’s streaming and movie studio businesses might lead to higher prices, Netflix Co-CEO Ted Sarados suggested in a Senate hearing today that any merger would have the opposite effect.

During the hearing, which was held by the US Senate Judiciary Committee’s Subcommittee on Antitrust, Competition Policy, and Consumer Rights, Sarandos sought to convince the senators that Netflix wouldn’t hold a streaming monopoly if regulators allow the acquisition to close.

Netflix is the largest subscription video-on-demand (SVOD) provider by subscribers (301.63 million as of January 2025), and WBD is the third (128 million streaming subscribers, including users of HBO Max and, to a lesser degree, Discovery+).

Read full article

Comments

Report: China approves import of high-end Nvidia AI chips after weeks of uncertainty 28 January 2026 at 12:21

Report: China approves import of high-end Nvidia AI chips after weeks of uncertainty

Ars Technica

By:Benj Edwards

28 January 2026 at 12:21

On Wednesday, China approved imports of Nvidia's H200 artificial intelligence chips for three of its largest technology companies, Reuters reported. ByteDance, Alibaba, and Tencent received approval to purchase more than 400,000 H200 chips in total, marking a shift in Beijing's stance after weeks of holding up shipments despite US export clearance.

The move follows Beijing's temporary halt to H200 shipments earlier this month after Washington cleared exports on January 13. Chinese customs authorities had told agents that the H200 chips were not permitted to enter China, Reuters reported earlier this month, even as Chinese technology companies placed orders for more than two million of the chips.

The H200, Nvidia's second most powerful AI chip after the B200, delivers roughly six times the performance of the company's H20 chip, which was previously the most capable chip Nvidia could sell to China. While Chinese companies such as Huawei now have products that rival the H20's performance, they still lag far behind the H200.

Read full article

Comments

Normal view

QMSR Framework Reshapes FDA Cybersecurity Guidance and Quality System Expectations

FDA Cybersecurity Guidance Emphasizes QMSR-Based Design, Risk, and Inspection Changes